Search Results
Aug 05, 2026, 17:07 ET Manulife Reports Second Quarter 2026 Results
As at Jun 30, 2026Mar 31, 2026
More news about: Manulife Financial Corporation
Aug 05, 2026, 17:07 ET Manulife Reports Second Quarter 2026 Results
As at Jun 30, 2026Mar 31, 2026
More news about: Manulife Financial Corporation
Aug 05, 2026, 16:30 ET Cboe Global Markets Reports Trading Volume for July 2026
%ChgJun 2026% Chg
More news about: Cboe Global Markets, Inc.
Aug 05, 2026, 16:15 ET Hennessy Advisors, Inc. Reports Quarterly Earnings and Announces Quarterly Dividend
Three Months Ended Jun 30,
More news about: Hennessy Advisors, Inc.
Aug 05, 2026, 16:09 ET Miami International Holdings Reports July 2026 Trading Results
% ChgJun-26% Chg
More news about: MIAX
Aug 05, 2026, 16:09 ET Miami International Holdings Reports July 2026 Trading Results
% ChgJun-26% Chg
More news about: MIAX
Aug 05, 2026, 16:05 ET Zillow Group Strengthens Executive Leadership Team with Promotions and Key Appointments
coordination and speed — from strategic and financial planning and capital allocation to the operational infrastructure that powers Zillow's growth. Jun Choo, who has held the role of chief operating officer since November 2024, is stepping down from the role to focus on his health and will serve in an
More news about: Zillow Group, Inc.
Aug 05, 2026, 16:01 ET Axon reports Q2 2026 revenue of $904 million, up 35% year over year
30 JUN 202530 JUN 2026
More news about: Axon
Aug 05, 2026, 10:00 ET Services PMI® at 54.1%; July 2026 ISM® Services PMI® Report
Series IndexJunPercent Point Change
More news about: Institute for Supply Management
Aug 05, 2026, 09:02 ET Francis Medical Announces Northwell Urology Group Performs First Commercial Vanquish® Water Vapor Ablation Procedure in New York
for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity. Journal of Urology [Internet]. [cited 2026 Jun 29];0(0). Available from:
More news about: Francis Medical, Inc.
Aug 05, 2026, 08:01 ET All Nippon Airways Builds Cloud Network Hub with Equinix
security and compliance through private connectivity, consistent centralized policy enforcement and alignment with modern security frameworks.Jun Nakazato, Manager, IT Infrastructure Team, Digital Governance Department, Digital Transformation Division, All Nippon Airways, said, "Our rapid business
More news about: Equinix, Inc.
Aug 05, 2026, 07:00 ET REGAL REXNORD REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
Jun 30,2026Jun 30,2025
More news about: Regal Rexnord Corporation
Aug 04, 2026, 16:15 ET EOG Resources Reports Second Quarter 2026 Results
MARJUNSEP
More news about: EOG Resources, Inc.
Aug 04, 2026, 12:30 ET Cornerstone Bancorp, Inc. Quarterly Report - June 30, 2026
30-Jun-2630-Jun-25
More news about: Cornerstone Bancorp, Inc.
Aug 04, 2026, 06:00 ET DuPont Reports Second Quarter 2026 Results
Jun 30, 2026Jun 30, 2025Jun 30, 2026
More news about: DuPont
Aug 03, 2026, 13:45 ET CJ 4DPLEX's SCREENX and 4DX Deliver Record-Breaking $31 Million Global Opening for Sony Pictures' Spider-Man: Brand New Day
4DPLEX's premium theatrical experiences."The global launch of Spider-Man: Brand New Day represents a defining moment for CJ 4DPLEX," said Jun Bang, CEO, CJ 4DPLEX. "In addition to delivering the biggest opening weekend in our company's history, we're proud that SCREENX set new records in 34
More news about: CJ 4DPLEX
Aug 03, 2026, 13:31 ET CJ 4DPLEX's SCREENX and 4DX Deliver Record-Breaking $31 Million Global Opening for Sony Pictures' Spider-Man: Brand New Day
4DPLEX's premium theatrical experiences."The global launch of Spider-Man: Brand New Day represents a defining moment for CJ 4DPLEX," said Jun Bang, CEO, CJ 4DPLEX. "In addition to delivering the biggest opening weekend in our company's history, we're proud that SCREENX set new records in 34
More news about: CJ 4DPLEX
Aug 03, 2026, 10:00 ET Manufacturing PMI® at 55.6%; July 2026 ISM® Manufacturing PMI® Report
SeriesIndexJunPercentage
More news about: Institute for Supply Management
Jul 31, 2026, 21:10 ET A CLASSYS nomeia Jun-oh Yoon, ex-vice-presidente executivo da Samsung Electronics, como CEO para liderar sua próxima fase de crescimento global.
CLASSYS (KOSDAQ: A Samsung Electronics (código 214150), empresa líder global em plataformas de estética médica, anunciou em 15 de julho a nomeação de Jun-oh Yoon, ex-vice-presidente executivo da Samsung Electronics, como seu novo diretor executivo (CEO), marcando o início oficial da próxima fase de crescimento
More news about: CLASSYS
Jul 31, 2026, 21:07 ET CLASSYS、グローバル成長の次段階を牽引するため、Samsung Electronicsの元執行副社長であるJun-oh Yoon氏をCEOに任命
Jun-oh Yoon氏は、Samsung GroupおよびSamsung Electronicsで成長戦略や将来の事業施策の策定に携わってきた豊富なリーダーシップ経験と、技術、事業、企業戦略、業務運営にわたる深い専門知識を有し、CLASSYSのCEOに就任しました。CLASSYSの最高経営責任者（CEO）であるJun-oh
More news about: CLASSYS
Jul 30, 2026, 16:05 ET Castle Biosciences Reports Second Quarter 2026 Results
execution, which continue to advance our mission of improving health through innovative tests that guide patient care."Second Quarter Ended Jun. 30, 2026, Financial and Operational HighlightsRevenues were $103.5 million, compared to $86.2 million in the second quarter
More news about: Castle Biosciences, Inc.
Jul 30, 2026, 16:05 ET Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer
11. Makker V, et al. Gynecol Oncol. 2024 Jun:185: 202-211 About XPOVIO® (selinexor)XPOVIO is a first-in-class, oral exportin 1 (XPO1) inhibitor
More news about: Karyopharm Therapeutics Inc.
Jul 30, 2026, 16:05 ET DIAMONDROCK HOSPITALITY COMPANY REPORTS SECOND QUARTER 2026 RESULTS
HiltonJun 2033Highgate Hotels
More news about: DiamondRock Hospitality Company
Jul 30, 2026, 08:30 ET Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer
Barsouk A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci (Basel). 2023;11(2):42. Published 2023 Jun 13. doi:10.3390/medsci110200428 Haddad RI, Ferrarotto R, Guo Y, et al. OrigAMI-5: A randomized, phase 3 study of amivantamab plus
More news about: Johnson & Johnson
Jul 30, 2026, 06:30 ET Spin Master Reports Q2 2026 Financial Results and Reiterates 2026 Full Year Outlook
Jun 30,2026Jun 30,2025
More news about: Spin Master Corp.